Study ID: TV50717-CNS-30047 | 2016-000630-22

Study Title

Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents

Teva Identifier

TV50717-CNS-30047 | 2016-000630-22

ClinicalTrials.gov Identifier

NCT03567291

Study Status

Terminated

Trial Condition(s)

Tourette Syndrome

Interventions

Drug: TEV-50717 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

6 Years to 17 Years

Trial Duration

May 25, 2018 - May 15, 2020

Phase

Phase 3

Study Type

Interventional